Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Hepatitis Monthly|January 10, 2014
GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics StudyMohammad Mahdi Ranjbar, Khodayar Ghorban, Seyed Moayed Alavian, et al.
Iranian Journal of Kidney Diseases|June 19, 2019
Preventive Effect of Trimetazidine on Contrast-Induced Acute Kidney Injury in CKD Patients Based on Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL): A randomized Clinical TrialAmirhossein Mirhosseni, Behzad Farahani, Alireza Gandomi-Mohammadabadi, et al.
Fetal and Pediatric Pathology|December 28, 2018
Rotavirus Infection Enhances Levels of Autoantibodies Against Islet Cell Antigens GAD65 and IA-2 in Children with Type 1 DiabetesAngila Ataei-Pirkooh, Mona Tehrani, Hossein Keyvani, et al.
Archives of Virology|February 10, 2017
HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individualsRouhollah Vahabpour, Farah Bokharaei-Salim, Saeed Kalantari, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 29, 2021
Dual role of microbiota-derived short-chain fatty acids on host and pathogenRasoul Mirzaei, Elahe Dehkhodaie, Behnaz Bouzari, et al.
Journal of Medical Virology|April 20, 2011
Occult hepatitis C virus infection in Iranian patients with cryptogenic liver diseaseFarah Bokharaei-Salim, Hossein Keyvani, Seyed Hamid Reza Monavari, et al.
Acta Cardiologica|December 1, 2017
Metabolic syndrome and cardiovascular risk assessment tools' estimations of 10-year cardiovascular risk: a population-based studyNima Motamed, Behnam Rabiee, Farzin Roozafzai, et al.
Archives of Virology|November 4, 2018
Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug usersMaryam Sheikh, Farah Bokharaei-Salim, Seyed Hamidreza Monavari, et al.
Pageof 19